Target intelligence / Profile preview

SEC31 homolog A, COPII coat complex component (SEC31A)

Target
SEC31A
Molecular classification
Other (Component of vesicle coat complex)
01

Overview

SEC31 homolog A, COPII coat complex component (SEC31A), is a structural component of the coat protein complex II (COPII) that regulates vesicle budding from the endoplasmic reticulum (ER) to the Golgi apparatus. SEC31A, a close functional homolog of yeast Sec31p, constitutes part of the outer shell of the COPII coat. It engages in both membrane deformation and cargo selection during ER vesicle formation, working together with other COPII subunits (Sar1, Sec23/24, Sec13) for efficient ER-to-Golgi transport of secretory proteins. In mammalian cells, SEC31A contains WD40 repeats and a proline-rich domain, interacts with SEC13, is regulated by monoubiquitylation (mediated by CUL3-KLHL12 to modulate vesicle size), and its membrane association is influenced by calcium-dependent ALG-2 binding. Mutations or dysregulation of SEC31A have been linked to rare syndromic diseases but it is not currently regarded as a direct therapeutic target for drugs[1][2][3][4][6].

Other names
Protein transport protein Sec31ASEC31AKIAA0905SEC31L1HSPC275HSPC334ABP125ABP130SEC31-like protein 1SEC31-related protein AWeb1-like proteinHPBKSNEDSOSByeast Sec31p homolog
02

Biological functions

Intracellular protein transportVesicle budding from the endoplasmic reticulumER-to-Golgi transportCargo selection and membrane deformation
03

Disease associations

Other (Associations with Halperin-Birk syndrome and soft tissue sarcoma have been reported but mechanistic links and therapeutic targeting are not established)

Beyond the preview

Go deeper on SEC31 homolog A, COPII coat complex component (SEC31A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SEC31 homolog A, COPII coat complex component (SEC31A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call